Magnesium Sulfate 50 % w/v Solution for Injection/Concentrate for solution for infusion アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

magnesium sulfate 50 % w/v solution for injection/concentrate for solution for infusion

aurum pharmaceutical limited - magnesium sulphate heptahydrate - solution for injection and concentrate for infusion - 50 percent weight/volume - electrolyte solutions; magnesium sulfate

Magnesium Sulfate 38.5% w/w Cutaneous Paste アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

magnesium sulfate 38.5% w/w cutaneous paste

foran healthcare limited, - magnesium sulfate dried - cutaneous paste - 38.5 percent weight/weight - other dermatologicals; magnesium sulfate

APO-METFORMIN XR 500 metformin hydrochloride 500 mg modified release tablet blister pack オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

apo-metformin xr 500 metformin hydrochloride 500 mg modified release tablet blister pack

arrotex pharmaceuticals pty ltd - metformin hydrochloride, quantity: 500 mg - tablet, modified release - excipient ingredients: povidone; colloidal anhydrous silica; hypromellose; magnesium stearate - treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. metformin modified release tablets may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.

APO-METFORMIN XR 1000 metformin hydrochloride 1000 mg modified release tablet blister pack オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

apo-metformin xr 1000 metformin hydrochloride 1000 mg modified release tablet blister pack

arrotex pharmaceuticals pty ltd - metformin hydrochloride, quantity: 1000 mg - tablet, modified release - excipient ingredients: povidone; colloidal anhydrous silica; hypromellose; magnesium stearate - treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. metformin modified release tablets may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.

BLOOMS THE CHEMIST METFORMIN XR 500 metformin hydrochloride 500 mg modified release tablet blister pack オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

blooms the chemist metformin xr 500 metformin hydrochloride 500 mg modified release tablet blister pack

gm pharma international pty ltd - metformin hydrochloride, quantity: 500 mg - tablet, modified release - excipient ingredients: povidone; colloidal anhydrous silica; hypromellose; magnesium stearate - treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. metformin modified release tablets may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.

BLOOMS THE CHEMIST METFORMIN XR 1000 metformin hydrochloride 1000 mg modified release tablet blister pack オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

blooms the chemist metformin xr 1000 metformin hydrochloride 1000 mg modified release tablet blister pack

gm pharma international pty ltd - metformin hydrochloride, quantity: 1000 mg - tablet, modified release - excipient ingredients: povidone; colloidal anhydrous silica; hypromellose; magnesium stearate - treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. metformin modified release tablets may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.

IBAVYR ribavirin 200 mg film coated tablets bottle オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

ibavyr ribavirin 200 mg film coated tablets bottle

clinect pty ltd - ribavirin, quantity: 200 mg - tablet, film coated - excipient ingredients: povidone; croscarmellose sodium; microcrystalline cellulose; crospovidone; silicon dioxide; magnesium stearate; titanium dioxide; macrogol 8000; hypromellose; purified talc - ibavyr (ribavirin tablets) is indicated in combination with other oral agents for the treatment of chronic hepatitis c (chc) in adults.

ABACAVIR/LAMIVUDINE 600/300 APOTEX abacavir 600mg (as sulfate) and lamivudine 300mg tablets bottle オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

abacavir/lamivudine 600/300 apotex abacavir 600mg (as sulfate) and lamivudine 300mg tablets bottle

arrotex pharmaceuticals pty ltd - lamivudine, quantity: 300 mg; abacavir sulfate, quantity: 702.76 mg (equivalent: abacavir, qty 600 mg) - tablet, film coated - excipient ingredients: hypromellose; titanium dioxide; sunset yellow fcf aluminium lake; macrogol 8000; croscarmellose sodium; magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose - abacavir and lamivudine combination tablets are a combination of two nucleoside analogues (abacavir and lamivudine). ,abacavir and lamivudine combination tablets are indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection in adults and adolescents from 12 years of age.

METEX XR metformin hydrochloride 500 mg modified release tablet blister pack オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

metex xr metformin hydrochloride 500 mg modified release tablet blister pack

arrotex pharmaceuticals pty ltd - metformin hydrochloride, quantity: 500 mg - tablet, modified release - excipient ingredients: colloidal anhydrous silica; magnesium stearate; povidone; hypromellose - treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. metformin modified release tablets may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.

METEX XR metformin hydrochloride 1000 mg modified release tablet blister pack オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

metex xr metformin hydrochloride 1000 mg modified release tablet blister pack

arrotex pharmaceuticals pty ltd - metformin hydrochloride, quantity: 1000 mg - tablet, modified release - excipient ingredients: hypromellose; povidone; magnesium stearate; colloidal anhydrous silica - treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. metformin modified release tablets may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.